177 related articles for article (PubMed ID: 36039935)
1. Downregulation of
Tian J; Li Z; Jiang Y; Gu W; Kong E; Hao Q; Kong B; Sun L
Rejuvenation Res; 2022 Oct; 25(5):243-252. PubMed ID: 36039935
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z
J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129
[TBL] [Abstract][Full Text] [Related]
3. LncRNA Opa interacting protein 5-antisense RNA 1 (OIP5-AS1) promotes the migration, invasion and epithelial-mesenchymal transition (EMT) through targeting miR-147a/insulin-like growth factor 1 receptor (IGF1R) pathway in cervical cancer tissues and cell model.
Zhang L; Cai Y; Tian C; Li Y; Ma K; Gao X; Liu L; Jiang Y; Wen W; Ma Z
J Obstet Gynaecol Res; 2022 May; 48(5):1222-1232. PubMed ID: 35233882
[TBL] [Abstract][Full Text] [Related]
4. TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines.
Liu Y; Liu L; Mou ZX
Biochem Genet; 2022 Feb; 60(1):173-190. PubMed ID: 34143331
[TBL] [Abstract][Full Text] [Related]
5. miR-96-5p regulates cervical cancer cell resistance to cisplatin by inhibiting lncRNA TRIM52-AS1 and promoting IGF2BP2.
Wu EY; Huang LP; Bao JH
Kaohsiung J Med Sci; 2022 Dec; 38(12):1178-1189. PubMed ID: 36354205
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA SOX21-AS1 modulates lung cancer progress upon microRNA miR-24-3p/PIM2 axis.
Wang F; Gu T; Chen Y; Chen Y; Xiong D; Zhu Y
Bioengineered; 2021 Dec; 12(1):6724-6737. PubMed ID: 34511042
[TBL] [Abstract][Full Text] [Related]
7. linc00958/miR-185-5p/RSF-1 modulates cisplatin resistance and angiogenesis through AKT1/GSK3β/VEGFA pathway in cervical cancer.
Tian J; Cheng L; Kong E; Gu W; Jiang Y; Hao Q; Kong B; Sun L
Reprod Biol Endocrinol; 2022 Sep; 20(1):132. PubMed ID: 36056431
[TBL] [Abstract][Full Text] [Related]
8. Role of microRNA-4739 in enhancing cisplatin chemosensitivity by negative regulation of RHBDD2 in human cervical cancer cells.
Li Y; Zhou Z; Qu J; Gong P; Wei Y; Sun Y
Cell Mol Biol Lett; 2024 Jan; 29(1):20. PubMed ID: 38267862
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA SOX21-AS1 promotes cell proliferation and invasion through upregulating PAK7 expression by sponging miR-144-3p in glioma cells.
Gai SY; Yuan ZH
Neoplasma; 2020 Mar; 67(2):333-343. PubMed ID: 31973536
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lncRNA DCST1-AS1 suppresses proliferation, migration and invasion of cervical cancer cells by increasing miR-874-3p expression.
Liu J; Zhang J; Hu Y; Zou H; Zhang X; Hu X
J Gene Med; 2021 Jan; 23(1):e3281. PubMed ID: 33025624
[TBL] [Abstract][Full Text] [Related]
11. LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis.
Liu Y; Guo R; Qiao Y; Han L; Liu M
Cancer Cell Int; 2020; 20():190. PubMed ID: 32489326
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
[TBL] [Abstract][Full Text] [Related]
13.
Chi C; Mao M; Shen Z; Chen Y; Chen J; Hou W
Hum Gene Ther; 2018 Dec; 29(12):1438-1448. PubMed ID: 29896986
[TBL] [Abstract][Full Text] [Related]
14. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
Yan SP; Chu DX; Qiu HF; Xie Y; Wang CF; Zhang JY; Li WC; Guo RX
J Cell Mol Med; 2019 Apr; 23(4):2656-2666. PubMed ID: 30697971
[TBL] [Abstract][Full Text] [Related]
15. Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer.
Wang Z; Li F; He S; Zhao L; Wang F
Gene; 2022 Jan; 809():146003. PubMed ID: 34648915
[TBL] [Abstract][Full Text] [Related]
16. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
Wei L; Qin XP; Zhao XX; Wang W
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
[No Abstract] [Full Text] [Related]
17. Long non-coding RNA
Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
[TBL] [Abstract][Full Text] [Related]
18. miR-34b-3p-mediated regulation of STC2 and FN1 enhances chemosensitivity and inhibits proliferation in cervical cancer.
Jin S; Wang W; Xu X; Yu Z; Feng Z; Xie J; Lv H
Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(5):740-752. PubMed ID: 38477044
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA ZNF667-AS1 reduces tumor invasion and metastasis in cervical cancer by counteracting microRNA-93-3p-dependent PEG3 downregulation.
Li YJ; Yang Z; Wang YY; Wang Y
Mol Oncol; 2019 Nov; 13(11):2375-2392. PubMed ID: 31420931
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-106a-5p alleviated the resistance of cisplatin in lung cancer cells by targeting Jumonji domain containing 6.
Ge X; Jiang Y; Hu X; Yu X
Transpl Immunol; 2021 Dec; 69():101478. PubMed ID: 34607003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
